Martin Stogniew

Marty was previously Chief Development Officer and Director at Oncoceutics, which was acquired by Chimerix in Q1 2021. He brings 39 years of senior executive experience in the pharmaceutical industry, and has led research and development resulting in FDA approval of nine New Drug Applications, issuance of 39 US patents, and five major biopharma exits for $3.5B in combined value.